MX2009005445A - Sistema de suministro para risperidona. - Google Patents

Sistema de suministro para risperidona.

Info

Publication number
MX2009005445A
MX2009005445A MX2009005445A MX2009005445A MX2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A
Authority
MX
Mexico
Prior art keywords
risperidone
delivery system
polymer
formulation
skin
Prior art date
Application number
MX2009005445A
Other languages
English (en)
Spanish (es)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005445A publication Critical patent/MX2009005445A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009005445A 2006-11-22 2007-11-21 Sistema de suministro para risperidona. MX2009005445A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062628 WO2008062009A1 (en) 2006-11-22 2007-11-21 Delivery system for risperidone

Publications (1)

Publication Number Publication Date
MX2009005445A true MX2009005445A (es) 2009-06-02

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Country Status (6)

Country Link
US (2) US20100203104A1 (enExample)
EP (2) EP2094270A1 (enExample)
JP (2) JP2010510286A (enExample)
CA (2) CA2670454A1 (enExample)
MX (2) MX2009005445A (enExample)
WO (2) WO2008062009A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP2037938A2 (en) * 2006-07-12 2009-03-25 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CA2670454A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for a non-steroidal non-ionized hydrophilic drug
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
US9078900B2 (en) * 2008-09-30 2015-07-14 Braeburn Pharmaceuticals Bvba Sprl Implantable device for the delivery of risperidone and methods of use thereof
EP2405967B1 (en) * 2009-03-12 2020-09-23 Delpor, Inc. Implantable device for long-term delivery of drugs
SG184059A1 (en) 2010-03-16 2012-10-30 Titan Pharmaceuticals Inc Heterogeneous implantable devices for drug delivery
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) * 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
KR20210013089A (ko) * 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
KR20210013088A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
WO1997002015A1 (en) * 1995-07-04 1997-01-23 Akzo Nobel N.V. Ring-shaped devices
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
CN1536986B (zh) * 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的阴道内药物递送装置
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
NZ537991A (en) * 2002-08-30 2007-08-31 Alza Corp Embossable and writable multilaminate backing construction
EP2633853A1 (en) * 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Long-term delivery formulations and methods of use thereof
JP2007530500A (ja) * 2004-03-24 2007-11-01 ナームローゼ・フエンノートチヤツプ・オルガノン ポリエチレン酢酸ビニル共重合体に基づく薬物送達システム
PL1824460T3 (pl) * 2004-11-10 2015-09-30 Tolmar Therapeutics Inc Stabilizowany polimerowy układ dostarczania
CA2669833A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
CA2670454A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for a non-steroidal non-ionized hydrophilic drug

Also Published As

Publication number Publication date
US20100203104A1 (en) 2010-08-12
MX2009005444A (es) 2009-06-02
US20100104619A1 (en) 2010-04-29
CA2670454A1 (en) 2008-05-29
CA2670157A1 (en) 2008-05-29
JP2010510287A (ja) 2010-04-02
WO2008062008A1 (en) 2008-05-29
JP2010510286A (ja) 2010-04-02
EP2094270A1 (en) 2009-09-02
EP2094348A1 (en) 2009-09-02
WO2008062009A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
MX2009005445A (es) Sistema de suministro para risperidona.
WO2010057082A3 (en) Diagnostic capsules, delivery/retrieval systems, kits and methods
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
WO2012091748A3 (en) Therapeutic agent reservoir delivery system
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
WO2008148478A8 (de) Gastroretentives system mit alginat-körper
CA2770353C (en) Insertion device systems and methods
MX2009005446A (es) Sistema de suministro vaginal para mirtazapina.
WO2008093851A1 (ja) 体腔用医療機器及びその製造方法
WO2008101486A3 (de) Beschichtetes expandierbares system
WO2013085901A3 (en) Systems and methods for delivery of a medical device
WO2010035273A3 (en) Novel gastroretentive delivery system
WO2008063341A3 (en) Dual action, inhaled formulations providing both an immediate and sustained release profile
WO2010088697A3 (en) Antimicrobial accessory for an implantable medical device
CL2008003421A1 (es) Sistema de administracion intravaginal con un compartimiento que comprende drospirenona y un compartimiento, igual o diferente, con un estrogeno, cada compartimiento comprende un nucleo y una membrana que lo recubre que consisten de una composicion de polimero que contiene un elastomero basado en polidimetilsiloxano con grupos polioxido de alquileno.
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
WO2006084164A8 (en) Gastric retention and controlled release delivery system
WO2010105995A3 (en) Zoo-technical drug delivery device
WO2010019597A3 (en) Cyclo olefin polymer and copolymer medical devices
WO2010062589A3 (en) Device for delivery of antimicrobial agent into trans-dermal catheter
WO2007126531A3 (en) Methods and devices for deployment into a lumen
EP1998751A4 (en) Devices, systems and methods for medicament delivery
WO2010103365A3 (en) Sustained release composition of therapeutic agent
WO2009032737A3 (en) Systems and methods for delivering medication
WO2014179615A3 (en) Biodegradable copolymers, forming and using same

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal